Abbott Laboratories

Abbott Laboratories

ABT
Abbott LaboratoriesUS flagNew York Stock Exchange
132.99
USD
+0.58
(+0.44%)
7.71EPS
17.25P/E
231.38BMarket Cap
Jul 16Next Earn
Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.

Company Description

CEO
Mr. Robert B. Ford
Full Time Employees
114,000
Sector
Healthcare
Industry
Medical - Devices
Address
100 Abbott Park Road North Chicago IL United States of America 60064-6400
IPO Date
Mar 17, 1980
Website
abbott.com
Similar Companies
Business
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Company News

  • New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier

  • Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

  • ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise?

  • Abbott (ABT) Stock Dips While Market Gains: Key Facts

  • Abbott Declares 406th Consecutive Quarterly Dividend

  • 5 Dividend Kings Are Delivering Massive Total Returns of Up to 34% This Year

  • 5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off

  • NVST vs. ABT: Which Stock Should Value Investors Buy Now?

  • The Highest-Quality Dividend Contenders By Quality Scores

  • Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?

  • Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note

  • Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

  • Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds

  • Abbott (ABT) Rises Higher Than Market: Key Facts

  • Abbott Stock Gains Following FDA Approval of the Tendyne System

  • Best Dividend Aristocrats For June 2025

  • Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery

  • Abbott Laboratories: Why Wall Street's Skepticism Misses The Real Story

  • 4 Dividend Aristocrats Are Absolutely Crushing the S&P 500 in 2025

  • 2 Dividend Stocks to Buy With $500 and Hold Forever